- Innovation: Innovative ideas, innovative route to market, innovative product
- Growth: Exceptional growth, exceptional growth strategy
- Management, diversity and/or societal impact
Top Biotechnology Startups in Austria
Data sourced from Crunchbase and SemRush.
Hookipa Pharma: A clinical-stage biotechnology company headquartered in Austria, dedicated to advancing active immunization therapies for infectious diseases and oncology. Hookipa Pharma is at the forefront of developing best-in-class treatments that have the potential to revolutionize healthcare.
Nabriva Therapeutics: Leading the way in biopharmaceuticals, Nabriva Therapeutics is committed to advancing the research and development of antibiotics for the treatment of community and hospital infections. Their innovative approach to combating infectious diseases has garnered them recognition in the healthcare sector.
Allcyte: Prioritizing precision medicine and drug development with a patient-centric approach, Allcyte leverages high-content imaging and artificial intelligence. They are at the forefront of harnessing technology to tailor treatments and therapies for individual patients.
Celeris Therapeutics: Pioneering biotech company Celeris Therapeutics utilizes deep learning and lab automation to accelerate the drug discovery process, particularly in the realm of targeted protein degradation. Their innovative approach holds promise for the development of novel therapies that address critical medical needs.
Themis Bioscience: A visionary startup biotechnology company shaping the future of healthcare. Their commitment to innovation and groundbreaking research positions them as a key player in the biotech landscape. With a focus on addressing unmet medical needs.
Apeiron Biologics: is at the forefront of biotechnology, specializing in the discovery and development of groundbreaking cancer immunotherapies. Their relentless pursuit of innovative solutions is transforming the landscape of cancer treatment, offering new hope to patients worldwide.
AFFiRiS: Committed to advancing medical science, AFFiRiS is a pioneering biotech firm that develops tailor-made peptide vaccines for a range of critical conditions, including Alzheimer’s, Parkinson’s, atherosclerosis, hypertension, and more. Their research is revolutionizing the field of personalized medicine.
OncoOne: a dynamic biotech startup, is dedicated to pushing the boundaries of therapeutic innovation. Their mission centers on the development of cutting-edge treatments that have the potential to reshape the future of healthcare, offering new possibilities for patients and healthcare providers alike.
lifebrain: Based in Austria, lifebrain operates as a strategic holding company with a significant presence in the laboratory diagnostics sector. Their investments and initiatives drive progress in medical diagnostics, ensuring that healthcare providers have access to state-of-the-art technologies for accurate and timely diagnoses.
PhagoMed: is pioneering the future of biotech with its innovative platform designed for the development of drugs and therapies. Their commitment to research and development positions them at the forefront of medical innovation, with the potential to address pressing healthcare challenges.
Sarcura: is leading the way with its integration of cutting-edge technologies into state-of-the-art GAMP automation. Their innovative approach is poised to revolutionize cell manufacturing, taking it to new heights and offering potential benefits across various medical fields.
HeartBeat.bio: As a privately funded drug discovery company, HeartBeat.bio is driving advancements in the healthcare industry. Their primary focus is on developing a high-throughput 3D screening platform, paving the way for more efficient drug discovery processes and potential breakthroughs in medical treatments.
Ares Genetics GmbH: leverages Artificial Intelligence-informed DNA-Sequencing Tests to transform Infectious Disease and Drug Resistance Testing. Their innovative approach has the potential to significantly improve diagnostics and treatment strategies in the ever-evolving field of healthcare.
Biocrates Life Sciences: is dedicated to providing valuable insights into the physiological state of organisms. By analyzing specific biological inputs, they contribute to a deeper understanding of health, offering vital information for healthcare professionals and researchers alike.
a: head bio: is on a mission to revolutionize the treatment of brain disorders. Their focus on developing innovative therapeutics using human cerebral organoids as a foundation holds the promise of significant advancements in neurological healthcare.
Vira Therapeutics: specializes in the development of highly potent anti-cancer therapeutics based on oncolytic viruses. Their cutting-edge research is opening new avenues in the fight against cancer, offering potential breakthroughs in cancer treatment.
Innovacell: is a forward-thinking biotechnology firm with a clear mission: to advance cell-tissue therapy for the treatment of incontinence. Their innovative approach addresses a critical medical need, potentially improving the quality of life for countless individuals.
EUCODIS Bioscience: is a leader in delivering high-performance enzyme solutions. Their expertise spans various industries, including chemical, cosmetics, and pharmaceuticals, making them a trusted partner for businesses seeking innovative enzymatic solutions.
Marinomed: is a biopharmaceutical company dedicated to developing innovative treatments for viruses and immune-related conditions. Their groundbreaking research holds the potential to transform healthcare and improve the lives of patients.
Pregenerate: is driving progress in drug development and personalized medicine for arthritis through the use of disease-on-a-chip models. Their innovative approach offers hope for more effective treatments and improved outcomes for patients dealing with this challenging condition.
VALANX Biotech: offers a cutting-edge platform for site-specific protein conjugation. This technology enables the fast and cost-efficient development of protein-drug conjugates, with the potential to revolutionize drug delivery and treatment strategies.
TAmiRNA: is a specialized biotech company dedicated to the discovery and validation of microRNA biomarkers. Their research has far-reaching implications for diagnostics and personalized medicine, with the potential to significantly improve patient care.
CYPRUMED: is a biopharmaceutical company that focuses on driving healthcare progress through innovative research and development endeavors. Their commitment to addressing unmet medical needs positions them as a key player in the healthcare industry.
3D Spine Matrix Biotechnology: This visionary company is on a mission to restore mobility and enhance the quality of life for patients in their living and working environments, with a focus on developing innovative solutions for spine-related treatments.
Zytoprotec: Austria’s biotechnology company focuses on developing innovative treatments for significant diseases. Their innovative research and development efforts are focused on addressing critical medical challenges and improving patient outcomes. With a commitment to advancing healthcare.
BRI.Tech GMBH: is revolutionizing orthopedic and trauma surgery by eliminating the need for a second surgical intervention. Their groundbreaking approach holds immense promise for improving patient care and outcomes. By pushing the boundaries of medical innovation, BRI.Tech is at the forefront of advancing orthopedic and trauma surgery.
Antibody Lab GmbH: is a dynamic company specializing in the development of immunoassays and preclinical biologics for partners and customers. Their expertise in immunoassays and biologics positions them as key contributors to advancements in medical research and diagnostics.
Briefcase Biotec: The company is dedicated to developing KiloBaser, a revolutionary DNA synthesis technology often likened to a Nespresso machine. This innovative approach streamlines DNA synthesis, enabling cutting-edge research without unnecessary detours.
Austrianova: Based in Singapore, is a cutting-edge Biotech company known for embracing leading world quality standards for production. Their commitment to excellence in biotechnology positions them as a global leader in biopharmaceutical research and development. With a focus on innovation and quality, Austrianova is shaping the future of biotechnology.
Impress Medtech: The company is a pioneering technology for continuous blood pressure monitoring during surgery, offering a crucial advancement in medical care. Their innovative approach has the potential to enhance patient safety and surgical outcomes. By pushing the boundaries of medical technology.
Ribbon Biolabs: The company is redefining standards in molecular biology by applying innovative methods for DNA synthesis. Their cutting-edge research and development efforts are poised to advance the field of molecular biology, contributing to discoveries and breakthroughs.
AOP Orphan Pharmaceuticals: The company is actively engaged in the development, marketing, and distribution of medicines for orphan indications and complex diseases. Their dedication to addressing unmet medical needs positions them as key contributors to advancements in healthcare.
Delta 4: The company is a biotech startup driving the forefront of digital drug discovery and development. Their innovative approach leverages digital technology to accelerate drug discovery efforts, potentially leading to the development of more effective treatments for various medical conditions.
Lexogen: in Next-Generation Sequencing (NGS), transcriptomics, and RNA analysis, contributing to advancements in genomics research. Their cutting-edge technology and expertise in RNA analysis position them as key players in the field of genomics. With a commitment to precision and innovation.
MyBioma: offers A.I.-powered preventive microbiome diagnostics, enabling personalized healthcare. Their innovative approach to microbiome analysis has the potential to revolutionize preventive medicine and diagnostics. By harnessing the power of artificial intelligence, myoma is shaping the future of healthcare.
Coridon: The company is a pioneering company dedicated to developing DNA therapies for the prevention and treatment of viral infections and therapeutic vaccines for cancer treatment. Their innovative approach to immunotherapy positions them as key contributors to advancements in healthcare.
Intercell: The biotechnology company, is engaged in the design and development of vaccines for the prevention and treatment of infectious diseases. Their commitment to vaccine development is a critical contribution to global health. With a focus on infectious diseases, Intercell is making a meaningful impact on healthcare.
APEPTICO Forschung und Entwicklung: The company is a biotech dedicated to developing new peptide-based medicinal drugs for the treatment of severe and chronic diseases. Their innovative approach to peptide therapeutics holds immense promise for improving patient care and outcomes.
Biolitec: specializes in medical laser and fiber technology, making significant contributions to the medical device industry. Their cutting-edge technologies are used in various medical applications, enhancing patient care and surgical procedures. With a focus on medical laser technology, Biolitec is at the forefront of advancing healthcare.
Rentschler Fill Solutions: The company is an independent contract manufacturing organization (CMO) specializing in the aseptic filling of liquid and lyophilized biopharmaceutical products. Their commitment to aseptic manufacturing contributes to the production of safe and effective medications, improving patient health worldwide.
Aposcience AG: is a biopharmaceutical company dedicated to advancing medical research and treatment. Their commitment to innovation positions them as key contributors to the biotech industry, with a focus on improving patient outcomes and addressing critical medical challenges.
Joanneum Research: The company is a leading international research organization that specializes in developing solutions and technologies for businesses. Their multidisciplinary research efforts span various industries and contribute to advancements in technology and innovation. By bridging the gap between research and practical application.
ViruSure: is a privately owned biotech company specializing in the Virus and Prion Safety Testing of Biopharmaceutical Products. Their expertise in viral safety testing contributes to the production of safe and effective biopharmaceuticals. ViruSure’s commitment to quality and safety enhances the integrity of the biopharmaceutical industry.
Saphium: is dedicated to developing an all-natural, compostable, and non-toxic bioplastic. Their innovative approach to sustainable materials has the potential to significantly reduce the environmental impact of plastics. Saphium’s commitment to eco-friendly solutions aligns with the global effort to address environmental challenges.
Sola Diagnostics: Their cutting-edge approach to cancer risk assessment holds the potential to revolutionize early detection and prevention strategies. By harnessing the power of epigenetics, Sola Diagnostics is advancing personalized medicine and improving cancer outcomes.
Sealife Pharma: is an innovative drug development company. Their commitment to research and development positions them as key contributors to advancements in medical treatment. Sealife Pharma’s dedication to improving patient care has the potential to lead to the development of groundbreaking therapies.
AlcaSynn Pharmaceuticals GmbH: The company is a drug development that focuses on small molecules of the morphinan group. Their research efforts aim to address medical needs through the development of innovative medications. AlcaSynn Pharmaceuticals GmbH’s commitment to drug development contributes to advancements in healthcare.
Zeta Biopharma: The specializes in the development and supply of tailored process and procedure solutions for sterile and aseptic applications. Their contributions to the pharmaceutical industry enhance the production of safe and effective medications.
G.ST Antivirals: specializes in the development of antiviral drugs. Their research efforts are dedicated to addressing critical medical challenges related to viral infections. G.ST Antivirals’ commitment to antiviral drug development contributes to the advancement of medical treatment.
KML VISION: provides cost-efficient access to modern automated image analysis for life science and industrial applications. Their innovative technology enhances research and quality control processes across various industries. KML VISION’s dedication to automation and efficiency improves the accuracy of scientific analysis and manufacturing.
Biomedica: is part of the AddLife Group, a publicly traded parent company. Their focus on healthcare solutions and diagnostics contributes to advancements in medical research and patient care. Biomedica’s commitment to providing innovative medical solutions aligns with the global effort to improve healthcare outcomes.
Ionophore: The specializes in enzyme discovery, drug discovery, and molecular dynamics simulation services. Their expertise in molecular biology and drug development contributes to advancements in the biotech industry. Innophore’s dedication to research and innovation positions them as key players in biopharmaceutical research.
Polymun Scientific: is committed to fostering the advancement of biopharmaceuticals as well as liposomal formulations. Their research and development efforts play a vital role in improving drug delivery and patient outcomes. Polymun Scientific’s dedication to pharmaceutical innovation contributes to advancements in medical treatment.
Research Institute of Molecular Pathology: Based in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. Their research efforts are focused on advancing our understanding of molecular biology and genetics, contributing to scientific progress in the field.
FERAGEN e.U.: The offers DNA tests for animals, serving as an expert in genetics and breeding. Their genetic testing services provide valuable insights into animal genetics and breeding programs. FERAGEN e.U.’s commitment to genetics contributes to the improvement of animal health and breeding practices.
DICE: is a dynamic and fast-growing company in the field of microelectronics with a strong focus on research and development. Their contributions to microelectronics research and innovation enhance technological advancements across various industries. DICE’s dedication to research and development drives progress in microelectronics.
BlueSky Vaccines: The mission is to maximize the potential of virotherapy against cancer. Their innovative approach to cancer treatment holds immense promise for improving patient outcomes. By harnessing the power of virotherapy, BlueSky Vaccines is at the forefront of advancing cancer immunotherapies.
The Siesta Group: is a Contract Research Organization (CRO) focused on polysomnography (PSG) and pharmaco-electroencephalography (pharmaco-EEG). Their services provide valuable insights into sleep and brain activity, contributing to advancements in medical research and drug development.
Anagnostics: develops systems and tests for research to provide solutions in protein and infectious disease diagnostics. Their innovative diagnostic solutions contribute to advancements in healthcare and research. Anagnostics’ commitment to diagnostics and research positions them as key contributors to improving patient care.
Institut Allergosan: The company is dedicated to developing, researching, and manufacturing probiotic products with a specific focus on intestinal health. Their innovative approach to probiotics and gut health contributes to advancements in the field of nutrition and wellness.
Krajete: The owns a proprietary technology for biochemical methane production from various industrial CO2 sources. This innovative technology addresses environmental challenges by converting industrial CO2 emissions into valuable methane gas.
Aelian Biotechnology: enables researchers to assess complex phenotypes, broadening the scope of their studies. Their innovative approach to phenotypic screening has the potential to accelerate scientific discoveries across various research fields.
BIRD-C: is a privately held R&D biotechnology company based in Vienna, Austria. Their research and development efforts focus on advancing biotechnology and life sciences. BIRD-C’s commitment to research positions them as key contributors to scientific progress in biotechnology.
Origimm: is an Austrian biotechnology company that specializes in the discovery of antigens and functional drug targets. Their research efforts contribute to advancements in drug discovery and development. Origimm’s dedication to identifying therapeutic targets plays a crucial role in improving medical treatment.
Center for Biomarker Research in Medicine
(CBmed): The company is an Austrian-funded competence center focused on biomarker research in medicine. Their multidisciplinary research efforts aim to improve medical diagnostics and personalized treatment approaches. CBmed’s commitment to biomarker research contributes to advancements in healthcare.
Vitateq Biotechnology: The company is a research-driven biotechnology company. Their research and development efforts are dedicated to advancing biotechnology and life sciences. Vitateq Biotechnology’s commitment to scientific progress contributes to discoveries and innovations in biotechnology.
Accanis Biotech: is developing optimized, proprietary in vitro transcription (IVT) mRNA with broad and long-acting therapeutic potential, surpassing protein-based therapeutics. Their innovative approach to mRNA therapeutics has the potential to revolutionize the treatment of various diseases.
orphan is: The company is a virtual pharmaceutical start-up focused on developing drug therapies for neglected and rare diseases known as orphan diseases. Their dedication to addressing unmet medical needs contributes to advancements in rare disease treatments.
S-TARget: is a biotech start-up company dedicated to developing novel therapeutic vaccines for curing and preventing allergic diseases. Their innovative approach to immunotherapy holds the potential to improve the lives of individuals with allergies.
H.M. Pharma Consultancy: The company is a new type of solution provider for the life science industry. Their services support and facilitate research and development efforts in the pharmaceutical and life sciences sectors. H.M. Pharma Consultancy’s commitment to providing solutions enhances the efficiency and progress of life science projects.
Antagonis: is a privately held company based in Graz, Austria. Their research efforts focus on advancing biotechnology and life sciences. Antagonis’ dedication to scientific progress contributes to discoveries and innovations in the biotech industry.
Austrian Centre of Industrial Biotechnology: replaces conventional industrial processes with new, more ecological, and economical methods inspired by nature. Their research and development efforts aim to promote sustainability and eco-friendly industrial practices.
Algonist Biotechnologies: is a pre-clinical stage biotechnology company that develops novel small molecule therapeutics for chronic pain. Their research and development efforts have the potential to improve pain management and patient quality of life.
Room Biotic: is a biotechnological start-up company that develops decontamination technologies based on airborne antimicrobial substances. Their innovative approach to decontamination contributes to improvements in environmental and healthcare hygiene.
CEBINA: The uniquely supports life science entrepreneurs and early-stage start-up companies while developing cutting-edge biotech projects. Their commitment to fostering innovation and entrepreneurship contributes to advancements in biotechnology.
Ludwig Boltzmann Gesellschaft: The (LBG) is a private organization for non-university research. Their research efforts encompass various scientific disciplines and contribute to advancements in knowledge and innovation. university research plays a vital role in expanding our understanding of the world.
ProFem: The specializes in developing medicines specifically for gynecological diseases with previously unmet medical needs. Their research and development efforts focus on improving women’s health and well-being. ProFem’s dedication to gynecological disease treatments contributes to advancements in women’s healthcare.
Bioplant R&D: develops and applies biotechnological methods to improve crop plants, contributing to food and energy supply security. Their research efforts play a crucial role in enhancing agricultural practices and ensuring sustainable food production.
LISAvienna: The company is the joint life science platform operated by Austria Wirtschaftsservice and the Vienna Business Agency. Their services support life science companies and entrepreneurs. LISAvienna’s commitment to the life sciences enhances the competitiveness of Vienna as a hub for biotech and healthcare innovation.
SemperSan: The produces sweet whey permeate sugar with proven and patented efficacy on diabetes. Their innovative approach to sugar production contributes to advancements in healthcare and diabetes management. SemperSan’s commitment to producing healthier sugar options aligns with global efforts to combat diabetes-related health issues.
Vienna Scientific Instruments: The collaborates with scientists to develop and build scientific equipment. Their dedication to providing cutting-edge equipment and solutions contributes to advancements in scientific research across various disciplines. Vienna Scientific Instruments’ commitment to serving the scientific community.
RD&C: offers a new systemic analysis concept for impurity profiling in pharmaceutical drug process development. Their innovative approach to analyzing pharmaceutical processes has the potential to improve drug development and safety. RD&C’s commitment to pharmaceutical research and development contributes to the quality of pharmaceutical products.
Igeneon: The specializes in cancer immunotherapy. Their research and development efforts focus on innovative approaches to cancer treatment, potentially improving patient outcomes. Igeneon’s dedication to cancer immunotherapy contributes to advancements in cancer care and therapy.
VOGELBUSCH Biocommodities: The company is the Austrian engineering office for the biotechnological industry. Their expertise in biotechnology engineering contributes to the development and optimization of biotechnological processes. VB’s commitment to biotechnology enhances the efficiency and sustainability of bioproduction.
Panoptes: is a privately held biotech company focused on developing small molecule-based therapies for the treatment of severe eye diseases. Their innovative approach to eye disease treatments has the potential to improve vision and quality of life for individuals with eye conditions.
OGOR: stands for the Austrian Society of Operations Research. Their focus on operations research contributes to advancements in decision-making and problem-solving across various industries. OGOR’s commitment to operations research enhances the efficiency and effectiveness of processes and systems.
ab&cd Innovations: The Innovations specializes in the development of strategies for the conversion of industrial waste or by-products into value-added chemicals. Their innovative approach to waste management and sustainability contributes to environmental conservation and resource optimization.
Molbi:otech is a biotechnology company that develops bioproducts. Their research and development efforts aim to advance biotechnology and life sciences. Molbiotech’s commitment to bioproduct development contributes to innovations in biotechnology applications and solutions.
By the way: If you’re a corporate or investor looking for exciting startups in a specific market for a potential investment or acquisition, check out our Startup Sourcing Service!
